We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+30.38%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$25.8M
Cap. Flow
-$106K
Cap. Flow %
-0.06%
Top 10 Hldgs %
49.87%
Holding
82
New
15
Increased
17
Reduced
25
Closed
12

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$3.26M
2
ESPR
Esperion Therapeutics
ESPR
+$1.11M
3
VZ icon
Verizon
VZ
+$984K
4
GLD icon
SPDR Gold Trust
GLD
+$806K
5
TGT icon
Target
TGT
+$571K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
2
XYZ
Block Inc
XYZ
+$1.05M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$740K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$639K
5
GM icon
General Motors
GM
+$623K

Sector Composition

Rank Sector Weight
1 Healthcare 37.65%
2 Miscellaneous 30.79%
3 Technology 15%
4 Communication Services 9.15%
5 Financials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$481B
$12.4M 6.93%
+50,000
New +$11.2M
GLD icon
2
SPDR Gold Trust
GLD
$147B
$11.7M 6.56%
70,000
+5,000
+8% +$806K
ITCI
3
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.9M 6.11%
425,500
-7,000
-2% -$142K
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$804B
$10.8M 6.04%
35,000
-83,500
-70% -$24.4M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.2T
$9.4M 5.26%
133,000
+4,000
+3% +$270K
MU icon
6
Micron Technology
MU
$1.09T
$8.11M 4.54%
157,500
-5,000
-3% -$236K
REGN icon
7
Regeneron Pharmaceuticals
REGN
$80.1B
$7.73M 4.33%
12,400
+250
+2% +$142K
XNCR icon
8
Xencor
XNCR
$1.81B
$6.17M 3.45%
190,367
+106,367
+127% +$3.26M
INCY icon
9
Incyte
INCY
$25.5B
$6.08M 3.4%
58,500
-1,300
-2% -$125K
ABBV icon
10
AbbVie
ABBV
$463B
$5.81M 3.25%
59,150
-6,000
-9% -$528K
ARGX icon
11
argenx
ARGX
$62B
$5.41M 3.03%
24,000
– –
ORCL icon
12
Oracle
ORCL
$449B
$4.7M 2.63%
85,000
– –
ALNY icon
13
Alnylam Pharmaceuticals
ALNY
$32.8B
$4.07M 2.28%
27,500
-1,500
-5% -$202K
BAC icon
14
Bank of America
BAC
$407B
$3.98M 2.23%
167,500
– –
AMD icon
15
Advanced Micro Devices
AMD
$869B
$3.95M 2.21%
75,000
-10,000
-12% -$530K
T icon
16
AT&T
T
$177B
$3.78M 2.11%
165,500
-17,212
-9% -$392K
IAU icon
17
iShares Gold Trust
IAU
$64.7B
$3.4M 1.9%
100,000
– –
C icon
18
Citigroup
C
$224B
$3.32M 1.86%
65,000
-10,000
-13% -$474K
VZ icon
19
Verizon
VZ
$207B
$3.17M 1.77%
57,500
+17,500
+44% +$984K
FMS icon
20
Fresenius Medical Care
FMS
$12.1B
$2.88M 1.61%
66,500
– –
AMGN icon
21
Amgen
AMGN
$204B
$2.77M 1.55%
11,750
-1,500
-11% -$342K
ESPR
22
DELISTED
Esperion Therapeutics
ESPR
$2.49M 1.39%
48,500
+26,500
+120% +$1.11M
GDX icon
23
VanEck Gold Miners ETF
GDX
$28.7B
$2.48M 1.39%
67,500
-22,500
-25% -$740K
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
$2.38M 1.33%
14,000
-3,000
-18% -$448K
BMY icon
25
Bristol-Myers Squibb
BMY
$131B
$2.35M 1.32%
40,000
-19,000
-32% -$1.14M
1
2 3 4

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, DCF Advisers held 82 positions worth $179M, up 17% from $153M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers's Q2 2020 filing shows 15 new, 17 increased, 25 reduced and 12 closed positions. Its largest new stake was Target: 5,000 shares worth $600K. The largest sale was Bristol-Myers Squibb, an estimated $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Technology.

  • DCF Advisers's largest Q2 2020 buy was Target: 5,000 shares worth $600K.
  • DCF Advisers added most to Xencor in Q2 2020, an estimated $3.26M increase.
  • DCF Advisers's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.14M.
  • DCF Advisers fully exited Block Inc in Q2 2020, selling an estimated $1.05M.
  • DCF Advisers's ten largest holdings make up 50% of its $179M portfolio in Q2 2020.
  • DCF Advisers opened 15 new positions and closed 12 in Q2 2020.
  • DCF Advisers's portfolio value rose 17% quarter-over-quarter to $179M.

Based on DCF Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.